One analyst predicted COVID boosters alone will bring in about $26 billion in global sales next year for Pfizer — who splits profits with BioNTech — and around $14 billion for Moderna if the shots are endorsed for nearly all Americans.
On Sept. 26, Pfizer CEO and Chairman Albert Bourla predicted life will return to normal within a year, but it’s likely annual COVID vaccinations will be necessary.
Bourla’s vision for a “return to normal life” would position Pfizer and Moderna to make billions in profits dispensing endless booster doses. How much the manufacturers stand to gain depends on how big the rollout is.